These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial. Lincoff AM, Califf RM, Van de Werf F, Willerson JT, White HD, Armstrong PW, Guetta V, Gibler WB, Hochman JS, Bode C, Vahanian A, Steg PG, Ardissino D, Savonitto S, Bar F, Sadowski Z, Betriu A, Booth JE, Wolski K, Waller M, Topol EJ, Global Use of Strategies To Open Coronary Arteries Investigators (GUSTO). JAMA; 2002 Nov 06; 288(17):2130-5. PubMed ID: 12413372 [Abstract] [Full Text] [Related]
7. Safety and feasibility of intraarterial eptifibatide as a revascularization tool in acute ischemic stroke. Memon MZ, Natarajan SK, Sharma J, Mathews MS, Snyder KV, Siddiqui AH, Hopkins LN, Levy EI. J Neurosurg; 2011 Apr 06; 114(4):1008-13. PubMed ID: 20868216 [Abstract] [Full Text] [Related]
8. Postprocedure intravenous eptifibatide following intra-arterial reteplase in patients with acute ischemic stroke. Qureshi AI, Hussein HM, Janjua N, Harris-Lane P, Ezzeddine MA. J Neuroimaging; 2008 Jan 06; 18(1):50-5. PubMed ID: 18190496 [Abstract] [Full Text] [Related]
12. Initial experience with the combination of reteplase and abciximab for thrombolytic therapy in peripheral arterial occlusive disease: a pilot study. Drescher P, Crain MR, Rilling WS. J Vasc Interv Radiol; 2002 Jan 06; 13(1):37-43. PubMed ID: 11788692 [Abstract] [Full Text] [Related]
13. Peripheral arteries: treatment with antibodies of platelet receptors and reteplase for thrombolysis--APART trial. Tepe G, Hopfenzitz C, Dietz K, Wiskirchen J, Heller S, Ouriel K, Ziemer G, Claussen CD, Duda SH. Radiology; 2006 Jun 06; 239(3):892-900. PubMed ID: 16641342 [Abstract] [Full Text] [Related]